MedTrace Logo

Ghrelin Levels in Pancreatic Cancer Patients

NCT00225745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2015-10-14

No results posted yet for this study

Summary

The primary outcome measure for this study is plasma ghrelin level.

Conditions

Interventions

PROCEDURE

Blood draw

One blood draw prior to first treatment

Sponsors & Collaborators

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • J Marc Pipas, MD · Dartmouth-Hitchcock Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2013-10-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00225745 on ClinicalTrials.gov